Analysts expect over 2018 decreasing revenue Novozymes

Tomorrow the Danish company Novozymes will publish its past quarters results. For this year Novozymes's revenue will be around 14,49 billion Danish Krone. This is according to the average of the analysts' estimates. This is slightly lower than 2017's revenue of 14,53 billion Danish Krone.

Historical revenues and results Novozymes plus estimates 2018

The analysts expect for 2018 a net profit of 3,22 billion Danish Krone. Most of the analysts anticipate on a profit per share of 10,97 Danish Krone. So the price/earnings-ratio equals 26,74.

Per share the analysts expect a dividend of 4,89 Danish Krone per share. Novozymes's dividend yield thus equals 1,67 percent. The average dividend yield of the chemical companies is a poor 1 percent.

Based on the current number of outstanding shares Novozymes's market capitalization 71,53 billion Danish Krone. The Novozymes stock was the past 12 months quite volatile. Since last January the stock is 12 percent lower. This year the stock price moved between 260 and 363 DKK. Since 2008 the stock price is almost 227 percent higher.

Historical stock prices Novozymes

ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.